Momoko Fukuda
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Albumin to Globulin Ratio Is an Independent Prognostic and Predictive Factor for Recurrence of Esophageal Cancer After Esophagectomy.
Journal: In vivo (Athens, Greece)
Published: March 18, 2026
The Systemic Immune-inflammation Index (SII) Is an Independent Prognostic Factor for Patients With Recurrent Esophageal Cancer After Esophagectomy.
Journal: In vivo (Athens, Greece)
Published: March 27, 2025
Lymphocyte-to-C-reactive Protein Ratio as an Independent Prognostic Factor for Patients With Gastric Cancer Who Received Curative Treatment.
Journal: Cancer diagnosis & prognosis
Published: February 26, 2025
Preoperative Anemia Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment.
Journal: In vivo (Athens, Greece)
Published: January 21, 2025
CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment.
Journal: Anticancer research
Published: December 06, 2023
Albumin-Globulin Ratio Is an Independent Prognostic Factor for Gastric Cancer Patients who Received Curative Treatment.
Journal: In vivo (Athens, Greece)
Published: November 23, 2023
Prognostic Nutritional Index as a Predictor of Prognosis in Postoperative Patients With Gastric Cancer.
Journal: In vivo (Athens, Greece)
Published: January 26, 2023
A case of esophageal cancer in a diverticulum treated by surgical resection: a case report.
Journal: General thoracic and cardiovascular surgery cases
Published: January 06, 2023
Prognostic Value of the Perioperative Systemic Inflammation Score for Patients With Curatively Resected Gastric Cancer.
Journal: Cancer diagnosis & prognosis
Published: July 29, 2022
Clinical Impact of Platelet-to-albumin Ratio on Esophageal Cancer Patients Who Receive Curative Treatment.
Journal: In vivo (Athens, Greece)
Published: April 04, 2022
The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.
Journal: In vivo (Athens, Greece)
Published: March 23, 2022
Last Updated: 09/26/2026